These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15224911)
1. [Migraine, juvenile rheumatoid arthritis, prevention of cancer. Potential of coxibs has not been exhausted]. MMW Fortschr Med; 2004 Apr; 146(17):57. PubMed ID: 15224911 [No Abstract] [Full Text] [Related]
2. The COX 2 selective inhibitors: what the newspapers have not told you. Simon LS Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675 [No Abstract] [Full Text] [Related]
3. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs. Jüni P; Dieppe P Age Ageing; 2004 Mar; 33(2):100-4. PubMed ID: 14960422 [No Abstract] [Full Text] [Related]
4. [Is there a future for COX-2 inhibitors?]. Yodfat Y Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272 [TBL] [Abstract][Full Text] [Related]
5. [Mobility and quality of life for arthrosis and rheumatism patients. Modern pain management with selective cox-2 inhibition]. MMW Fortschr Med; 2002 Jul; 144(29-30):52. PubMed ID: 12219613 [No Abstract] [Full Text] [Related]
6. Cardiorenal differences among NSAIDs and coxibs: real-world experience. Sonnenblick EH Am J Manag Care; 2002 Oct; 8(15 Suppl):S369-70. PubMed ID: 12416786 [No Abstract] [Full Text] [Related]
7. Coxibs and cardiovascular risk. Allen MJ; McLean-Veysey P; Fleming I CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098 [No Abstract] [Full Text] [Related]
8. [The status of coxibs]. Künzel D Krankenpfl J; 2004; 42(7-10):237. PubMed ID: 15675400 [No Abstract] [Full Text] [Related]
9. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference. Tannenbaum H; Bombardier C; Davis P; Russell AS; J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802 [TBL] [Abstract][Full Text] [Related]
10. [Alleviating pain and preventing inflammation with selective COX-2 inhibitors. Prescribing with confidence in the future]. MMW Fortschr Med; 2005 Mar; 147(9):12. PubMed ID: 15794346 [No Abstract] [Full Text] [Related]
14. [Proglumetacin in the treatment of rheumatoid arthritis and arthrosis]. Cianfanelli M; Fiermonte MA; Fiore D; Dardano B; Michela Zucco FR Clin Ter; 1988 Aug; 126(3):181-5. PubMed ID: 2974384 [No Abstract] [Full Text] [Related]
15. [Current EULAR data on valdecoxib. New study results of gastrointestinal safety and "cost effectiveness"]. Kellner H Krankenpfl J; 2004; 42(5-6):185. PubMed ID: 15527245 [No Abstract] [Full Text] [Related]
16. [Progress in therapy of rheumatism. New coxib works especially fast]. MMW Fortschr Med; 2003 Jun; 145(23):58. PubMed ID: 12854230 [No Abstract] [Full Text] [Related]
17. Introduction. New directions in anti-inflammatory therapy and pain management. Hochberg MC Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):1-3. PubMed ID: 12528068 [No Abstract] [Full Text] [Related]
18. Comment on Jüni P, Dieppe P. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs. Stichtenoth DO; Frölich JC Age Ageing; 2004 Sep; 33(5):521. PubMed ID: 15315931 [No Abstract] [Full Text] [Related]
19. Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis. Eisen GM; Goldstein JL; Hanna DB; Rublee DA Aliment Pharmacol Ther; 2005 Mar; 21(5):591-8. PubMed ID: 15740543 [TBL] [Abstract][Full Text] [Related]
20. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG; Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]